 | • レポートコード：QYR9ST04240 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、肺炎の世界市場について調査・分析し、肺炎の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物、ワクチン、酸素療法）、用途別（病院、外来手術センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の肺炎市場動向 ・主要企業別マーケットシェア ・肺炎の種類別市場規模2014-2019 （薬物、ワクチン、酸素療法） ・肺炎の用途別市場規模2014-2019 （病院、外来手術センター、その他） ・肺炎の北米市場：主要企業・種類別/用途別市場規模 ・肺炎のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・肺炎の中国市場：主要企業・種類別/用途別市場規模 ・肺炎の日本国内市場：主要企業・種類別/用途別市場規模 ・肺炎の東南アジア市場：主要企業・種類別/用途別市場規模 ・肺炎のインド市場：主要企業・種類別/用途別市場規模 ・肺炎の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、GlaxoSmithKline(GSK)、Merck、Novartis、Sanofi、Eli Lilly） ・肺炎の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. The global pneumonia therapeutics market is projected to expand at a significant pace during the forecast period, due to increase in the number of cases of pneumonia and advancement in treatments. Moreover, growing awareness about pneumonia treatment among patients, rising demand for treatment, increasing incidence of pneumonia, and improvement in diagnosis methods are promoting the growth of the global pneumonia therapeutics market.Increase in number of resistant strains and high rate of mortality & morbidity associated with pneumococcal infection have led to increased preference for prevention therapy. The high preventive rates of these vaccines, 5-year immunization schedule, and increasing support for vaccination by various regulatory agencies are expected to provide lucrative growth opportunities.
In 2018, the global Pneumonia market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Pneumonia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pneumonia development in United States, Europe and China.
The key players covered in this study
Pfizer
GlaxoSmithKline(GSK)
Merck
Novartis
Sanofi
Eli Lilly
…
Market segment by Type, the product can be split into
Drugs
Vaccines
Oxygen Therapy
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Pneumonia status, future forecast, growth opportunity, key market and key players.
To present the Pneumonia development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Pneumonia are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pneumonia Market Size Growth Rate by Type (2014-2025)
1.4.2 Drugs
1.4.3 Vaccines
1.4.4 Oxygen Therapy
1.5 Market by Application
1.5.1 Global Pneumonia Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Pneumonia Market Size
2.2 Pneumonia Growth Trends by Regions
2.2.1 Pneumonia Market Size by Regions (2014-2025)
2.2.2 Pneumonia Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Pneumonia Market Size by Manufacturers
3.1.1 Global Pneumonia Revenue by Manufacturers (2014-2019)
3.1.2 Global Pneumonia Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pneumonia Market Concentration Ratio (CR5 and HHI)
3.2 Pneumonia Key Players Head office and Area Served
3.3 Key Players Pneumonia Product/Solution/Service
3.4 Date of Enter into Pneumonia Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Pneumonia Market Size by Type (2014-2019)
4.2 Global Pneumonia Market Size by Application (2014-2019)
5 United States
5.1 United States Pneumonia Market Size (2014-2019)
5.2 Pneumonia Key Players in United States
5.3 United States Pneumonia Market Size by Type
5.4 United States Pneumonia Market Size by Application
6 Europe
6.1 Europe Pneumonia Market Size (2014-2019)
6.2 Pneumonia Key Players in Europe
6.3 Europe Pneumonia Market Size by Type
6.4 Europe Pneumonia Market Size by Application
7 China
7.1 China Pneumonia Market Size (2014-2019)
7.2 Pneumonia Key Players in China
7.3 China Pneumonia Market Size by Type
7.4 China Pneumonia Market Size by Application
8 Japan
8.1 Japan Pneumonia Market Size (2014-2019)
8.2 Pneumonia Key Players in Japan
8.3 Japan Pneumonia Market Size by Type
8.4 Japan Pneumonia Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Pneumonia Market Size (2014-2019)
9.2 Pneumonia Key Players in Southeast Asia
9.3 Southeast Asia Pneumonia Market Size by Type
9.4 Southeast Asia Pneumonia Market Size by Application
10 India
10.1 India Pneumonia Market Size (2014-2019)
10.2 Pneumonia Key Players in India
10.3 India Pneumonia Market Size by Type
10.4 India Pneumonia Market Size by Application
11 Central & South America
11.1 Central & South America Pneumonia Market Size (2014-2019)
11.2 Pneumonia Key Players in Central & South America
11.3 Central & South America Pneumonia Market Size by Type
11.4 Central & South America Pneumonia Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pneumonia Introduction
12.1.4 Pfizer Revenue in Pneumonia Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline(GSK)
12.2.1 GlaxoSmithKline(GSK) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pneumonia Introduction
12.2.4 GlaxoSmithKline(GSK) Revenue in Pneumonia Business (2014-2019)
12.2.5 GlaxoSmithKline(GSK) Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pneumonia Introduction
12.3.4 Merck Revenue in Pneumonia Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pneumonia Introduction
12.4.4 Novartis Revenue in Pneumonia Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pneumonia Introduction
12.5.4 Sanofi Revenue in Pneumonia Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 Eli Lilly
12.6.1 Eli Lilly Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pneumonia Introduction
12.6.4 Eli Lilly Revenue in Pneumonia Business (2014-2019)
12.6.5 Eli Lilly Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Pneumonia Key Market Segments
Table Key Players Pneumonia Covered
Table Global Pneumonia Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Pneumonia Market Size Market Share by Type 2014-2025
Figure Drugs Figures
Table Key Players of Drugs
Figure Vaccines Figures
Table Key Players of Vaccines
Figure Oxygen Therapy Figures
Table Key Players of Oxygen Therapy
Table Global Pneumonia Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Others Case Studies
Figure Pneumonia Report Years Considered
Table Global Pneumonia Market Size 2014-2025 (Million US$)
Figure Global Pneumonia Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Pneumonia Market Size by Regions 2014-2025 (Million US$)
Table Global Pneumonia Market Size by Regions 2014-2019 (Million US$)
Table Global Pneumonia Market Share by Regions 2014-2019
Figure Global Pneumonia Market Share by Regions 2014-2019
Figure Global Pneumonia Market Share by Regions 2019
Table Market Top Trends
Table Global Pneumonia Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Pneumonia Market Share by Manufacturers (2014-2019)
Figure Global Pneumonia Market Share by Manufacturers in 2018
Table Global Pneumonia Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Pneumonia Product/Solution/Service
Table Date of Enter into Pneumonia Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Pneumonia Market Size by Type (2014-2019) (Million US$)
Table Global Pneumonia Market Size Share by Type (2014-2019)
Figure Global Pneumonia Market Size Market Share by Type (2014-2019)
Table Global Pneumonia Market Size by Application (2014-2019) (Million US$)
Table Global Pneumonia Market Size Share by Application (2014-2019)
Figure Global Pneumonia Market Size Market Share by Application (2014-2019)
Figure Global Pneumonia Revenue Market Share by Application in 2018
Figure United States Pneumonia Market Size 2014-2019 (Million US$)
Table United States Key Players Pneumonia Revenue (2018-2019) (Million US$)
Table United States Key Players Pneumonia Market Share (2018-2019)
Table United States Pneumonia Market Size by Type (2014-2019) (Million US$)
Table United States Pneumonia Market Share by Type (2014-2019)
Table United States Pneumonia Market Size by Application (2014-2019) (Million US$)
Table United States Pneumonia Market Share by Application (2014-2019)
Figure Europe Pneumonia Market Size 2014-2019 (Million US$)
Table Europe Key Players Pneumonia Revenue (2018-2019) (Million US$)
Table Europe Key Players Pneumonia Market Share (2018-2019)
Table Europe Pneumonia Market Size by Type (2014-2019) (Million US$)
Table Europe Pneumonia Market Share by Type (2014-2019)
Table Europe Pneumonia Market Size by Application (2014-2019) (Million US$)
Table Europe Pneumonia Market Share by Application (2014-2019)
Figure China Pneumonia Market Size 2014-2019 (Million US$)
Table China Key Players Pneumonia Revenue (2018-2019) (Million US$)
Table China Key Players Pneumonia Market Share (2018-2019)
Table China Pneumonia Market Size by Type (2014-20189) (Million US$)
Table China Pneumonia Market Share by Type (2014-2019)
Table China Pneumonia Market Size by Application (2014-2019) (Million US$)
Table China Pneumonia Market Share by Application (2014-2019)
Figure Japan Pneumonia Market Size 2014-2019 (Million US$)
Table Japan Key Players Pneumonia Revenue (2018-2019) (Million US$)
Table Japan Key Players Pneumonia Market Share (2018-2019)
Table Japan Pneumonia Market Size by Type (2014-2019) (Million US$)
Table Japan Pneumonia Market Share by Type (2014-2019)
Table Japan Pneumonia Market Size by Application (2014-2019) (Million US$)
Table Japan Pneumonia Market Share by Application (2014-2019)
Figure Southeast Asia Pneumonia Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Pneumonia Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Pneumonia Market Share (2018-2019)
Table Southeast Asia Pneumonia Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Pneumonia Market Share by Type (2014-2019)
Table Southeast Asia Pneumonia Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Pneumonia Market Share by Application (2014-2019)
Figure India Pneumonia Market Size 2014-2019 (Million US$)
Table India Key Players Pneumonia Revenue (2018-2019) (Million US$)
Table India Key Players Pneumonia Market Share (2018-2019)
Table India Pneumonia Market Size by Type (2014-2019) (Million US$)
Table India Pneumonia Market Share by Type (2014-2019)
Table India Pneumonia Market Size by Application (2014-2019) (Million US$)
Table India Pneumonia Market Share by Application (2014-2019)
Figure Central & South America Pneumonia Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Pneumonia Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Pneumonia Market Share (2018-2019)
Table Central & South America Pneumonia Market Size by Type (2014-2019) (Million US$)
Table Central & South America Pneumonia Market Share by Type (2014-2019)
Table Central & South America Pneumonia Market Size by Application (2014-2019) (Million US$)
Table Central & South America Pneumonia Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Pneumonia Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Pneumonia Business (2014-2019)
Table Pfizer Recent Development
Table GlaxoSmithKline(GSK) Company Details
Table GlaxoSmithKline(GSK) Revenue in Pneumonia Business (2014-2019)(Million US$)
Figure GlaxoSmithKline(GSK) Revenue Growth Rate in Pneumonia Business (2014-2019)
Table GlaxoSmithKline(GSK) Recent Development
Table Merck Company Details
Table Merck Revenue in Pneumonia Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Pneumonia Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Pneumonia Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Pneumonia Business (2014-2019)
Table Novartis Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Pneumonia Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Pneumonia Business (2014-2019)
Table Sanofi Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Pneumonia Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Pneumonia Business (2014-2019)
Table Eli Lilly Recent Development
Table Global Pneumonia Market Size by Regions (Million US$) 2019-2025
Figure Global Pneumonia Market Size Share by Regions (2019-2025)
Figure Global Pneumonia Market Size Share by Regions in 2025
Figure United States Pneumonia Market Size Forecast (2019-2025)(Million USD)
Figure Europe Pneumonia Market Size Forecast (2019-2025)(Million USD)
Figure China Pneumonia Market Size Forecast (2019-2025)(Million USD)
Figure Japan Pneumonia Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Pneumonia Market Size Forecast (2019-2025)(Million USD)
Figure India Pneumonia Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Pneumonia Market Size Forecast (2019-2025)(Million USD)
Table Global Pneumonia Market Size by Product (2019-2025) (Million US$)
Figure Global Pneumonia Market Size by Product (2019-2025)
Figure Global Pneumonia Market Size by Product in 2025
Table Global Pneumonia Market Size by Application (2019-2025) (Million US$)
Figure Global Pneumonia Market Size by Application (2019-2025)
Figure Global Pneumonia Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
細菌性肺炎治療薬の世界市場：市場規模・現状・予測 Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affec…- 世界の院内感染肺炎薬パイプライン分析市場：専門的調査 Nosocomial or hospital acquired infections have created numerous complications for patients in hospitals throughout the world, as these infections are caused by multidrug resistant microorganisms, the recuperation of a patient is drastically reduced and accompanied by several comorbidities. Being mu…
- 院内感染肺炎予防の世界市場：インサイト・予測 HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…
- 肺炎検査の世界市場：インサイト・予測 Pneumonia is a complicated infection of the lower respiratory tract. It may start on or after an upper respiratory tract infection.The rising popularity of point-of-care (POC) testing as one of the primary growth factors for this market. The global Pneumonia Testing market is valued at xx million US…
- 酸素療法機器の世界市場：インサイト・予測 Oxygen therapy, also known as supplemental oxygen, is the use of oxygen as a medical treatment. This can include for low blood oxygen, carbon monoxide toxicity, cluster headaches, and to maintain enough oxygen while inhaled anesthetics are given. Long term oxygen is often useful in people with chron…